Objective: Sinistral, or left-sided, portal hypertension (SPH) is a rare cause of upper gastrointestinal hemorrhage. This retrospective analysis summarizes the clinical features of SPH and the results of surgical treatment. Subjects and Methods: Between 2000 and 2009, patients from our hospital diagnosed with SPH were identified. Diagnosis of SPH was based on evidence of isolated splenic vein thrombosis, splenomegaly, gastroesophageal varices and exclusion of other causes of portal hypertension. Results: Eight males and 5 females were included in the study, with a mean age of 43.5 ± 6.4 years (range: 31–68 years). Liver function was normal in all patients. Causes of SPH were chronic pancreatitis (n = 7), pancreatic cancer (n = 3), pancreatic cysts (n = 2) and neuroendocrine tumor (n = 1). The main clinical manifestations were gastrointestinal hemorrhage in 7 cases (53.8%), upper abdominal pain in 10 (76.9%) and hypersplenism in 12 (92.3%). All patients had splenomegaly and gastroesophageal varices. Twelve patients underwent splenectomy and 1 received surgical removal of a pancreatic cyst. No major gastrointestinal tract rebleed occurred after a mean follow-up of 46 months (±7 months). Two patients died of pancreatic cancer and 1 of acute myocardial infarction during follow-up. Conclusions: SPH should be suspected in patients with upper gastrointestinal varices as well as unexplained splenomegaly with normal liver function. Surgical intervention such as splenectomy offers a good long-term outcome in symptomatic patients.

Keywords:
Portal hypertension, Pancreatic diseases, Splenomegaly, Gastric varices, isolated, Splenectomy
1.
Madsen MS, Petersen TH, Sommer H: Segmental portal hypertension. Ann Surg 1986;204:72–77.
2.
Evans GR, Yellin AE, Weaver FA, Stain SC: Sinistral (left-sided) portal hypertension. Am Surg 1990;56:758–763.
3.
Sakorafas GH, Sarr MG, Farley DR, Farnell MB: The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg 2000;179:129–133.
4.
Köklü S, Yüksel O, Arhan M, Coban S, Basar O, Yolcu OF, Uçar E, Ibis M, Ertugrul I, Sahin B: Report of 24 left-sided portal hypertension cases: a single-center prospective cohort study. Dig Dis Sci 2005;50:976–982.
5.
Köklü S, Coban S, Yüksel O, Arhan M: Left-sided portal hypertension. Dig Dis Sci 2007;52:1141–1149.
6.
Loftus JP, Nagorney DM, Illstrup D, Kunselman AR: Sinistral portal hypertension: splenectomy or expectant management. Ann Surg 1993;217:35–40.
7.
Thompson RJ, Taylor MA, McKie LD, Diamond T: Sinistral portal hypertension. Ulster Med J 2006;75:175–177.
8.
Pursnani KG, Sillin LF, Kaplan DS: Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. Am J Surg 1997;173:169–173.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.